IRIS Accounts Production v24.1.9.2 09229006 Board of Directors Board of Directors 1.10.22 30.9.23 30.9.23 0 0 false true false false true false Ordinary shares 1.00000 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092290062022-09-30092290062023-09-30092290062022-10-012023-09-30092290062021-09-30092290062021-10-012022-09-30092290062022-09-3009229006ns15:EnglandWales2022-10-012023-09-3009229006ns14:PoundSterling2022-10-012023-09-3009229006ns10:Director12022-10-012023-09-3009229006ns10:Director22022-10-012023-09-3009229006ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3009229006ns10:SmallEntities2022-10-012023-09-3009229006ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3009229006ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3009229006ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3009229006ns10:FullAccounts2022-10-012023-09-3009229006ns10:OrdinaryShareClass12022-10-012023-09-3009229006ns10:OrdinaryShareClass22022-10-012023-09-3009229006ns5:CurrentFinancialInstruments2023-09-3009229006ns5:CurrentFinancialInstruments2022-09-3009229006ns5:Non-currentFinancialInstruments2023-09-3009229006ns5:Non-currentFinancialInstruments2022-09-3009229006ns5:RetainedEarningsAccumulatedLosses2023-09-3009229006ns5:RetainedEarningsAccumulatedLosses2022-09-3009229006ns10:RegisteredOffice2022-10-012023-09-3009229006ns5:LandBuildings2022-09-3009229006ns5:LandBuildings2023-09-3009229006ns5:LandBuildings2022-09-3009229006ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3009229006ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3009229006ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-09-3009229006ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-09-3009229006ns10:OrdinaryShareClass12023-09-3009229006ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-30
REGISTERED NUMBER: 09229006 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2023

for

Medco Properties Limited

Medco Properties Limited (Registered number: 09229006)






Contents of the Financial Statements
for the Year Ended 30 September 2023




Page

Balance Sheet 1

Notes to the Financial Statements 3


Medco Properties Limited (Registered number: 09229006)

Balance Sheet
30 September 2023

30.9.23 30.9.22
Notes £ £
Fixed assets
Tangible assets 4 325,000 325,000

Current assets
Cash at bank 2,158 3,735

Creditors
Amounts falling due within one year 5 (45,939 ) (54,258 )
Net current liabilities (43,781 ) (50,523 )
Total assets less current liabilities 281,219 274,477

Creditors
Amounts falling due after more than
one year

6

(133,629

)

(143,126

)
Net assets 147,590 131,351

Capital and reserves
Called up share capital 8 100 100
Revaluation reserve 9 (25,200 ) (25,200 )
Retained earnings 9 172,690 156,451
Shareholders' funds 147,590 131,351

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medco Properties Limited (Registered number: 09229006)

Balance Sheet - continued
30 September 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 June 2024 and were signed on its behalf by:




Mohamad Al-Dujaili - Director



Mrs Zainab Mahmoud - Director


Medco Properties Limited (Registered number: 09229006)

Notes to the Financial Statements
for the Year Ended 30 September 2023

1. Statutory information

Medco Properties Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09229006

Registered office: Medco House
Monument Way East
Woking
Surrey
GU21 5LY

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Medco Properties Limited (Registered number: 09229006)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

3. Employees and directors

The average number of employees during the year was NIL (2022 - NIL).

4. Tangible fixed assets
Freehold
property
£
Cost
At 1 October 2022
and 30 September 2023 325,000
Net book value
At 30 September 2023 325,000
At 30 September 2022 325,000

5. Creditors: amounts falling due within one year
30.9.23 30.9.22
£ £
Bank loans and overdrafts (see note 7)
7,250

11,750
Trade creditors - 2,278
Corporation tax 3,809 6,102
Other creditors 34,880 30,778
Other creditors - 3,350
45,939 54,258

6. Creditors: amounts falling due after more than one year
30.9.23 30.9.22
£ £
Bank loans (see note 7) 133,629 143,126

7. Loans

An analysis of the maturity of loans is given below:

30.9.23 30.9.22
£ £
Amounts falling due within one year or on demand:
Bank loans < 1 year 7,250 11,750

Amounts falling due between one and two years:
Bank loans > 1 year 133,629 143,126

Medco Properties Limited (Registered number: 09229006)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

8. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.23 30.9.22
value: £ £
100 Ordinary shares 1 100 100
NIL - -
100 100

9. Reserves
Retained Revaluation
earnings reserve Totals
£ £ £

At 1 October 2022 156,451 (25,200 ) 131,251
Profit for the year 16,239 16,239
At 30 September 2023 172,690 (25,200 ) 147,490